|
Volumn 22, Issue 3, 2014, Pages 1104-1114
|
Design, synthesis and ex-vivo release studies of colon-specific polyphosphazene-anticancer drug conjugates
|
Author keywords
Azoreductase; Colon specific; Gemcitabine; Methotrexate; Polyphosphazene
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BALSALAZIDE;
BUTANOL;
IPSALAZINE;
MESALAZINE;
METHOTREXATE;
OLSALAZINE;
POLYMER;
POLYPHOSPHAZENE;
POLYPHOSPHAZENE ANTICANCER DRUG CONJUGATE;
POLYPHOSPHAZENE GEMCITABINE CONJUGATE;
POLYPHOSPHAZENE METHOTREXATE CONJUGATE;
SALAZOSULFAPYRIDINE;
UNCLASSIFIED DRUG;
ACIDITY;
ANIMAL TISSUE;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL;
CECUM;
COLON;
COLORECTAL CANCER;
CONTROLLED STUDY;
DRUG CONJUGATION;
DRUG CYTOTOXICITY;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
DRUG FORMULATION;
DRUG RELEASE;
DRUG SPECIFICITY;
DRUG STABILITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
EX VIVO STUDY;
HUMAN;
HUMAN CELL;
NONHUMAN;
RAT;
RATTUS;
AZOREDUCTASE;
COLON-SPECIFIC;
GEMCITABINE;
METHOTREXATE;
POLYPHOSPHAZENE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL LINE, TUMOR;
COLON;
COLORECTAL NEOPLASMS;
DEOXYCYTIDINE;
DRUG CARRIERS;
DRUG DELIVERY SYSTEMS;
DRUG DESIGN;
HT29 CELLS;
HUMANS;
METHOTREXATE;
ORGANOPHOSPHORUS COMPOUNDS;
POLYMERS;
RATS;
|
EID: 84892812241
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2013.12.037 Document Type: Article |
Times cited : (38)
|
References (40)
|